Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report

Journal of Affective Disorders

Volumn 133, Issue 3, 2011, Pages 467-476

  Bobo, William V ^a   Chen, Helen ^b   Trivedi, Madhukar H ^c   Stewart, Jonathan W ^d   Nierenberg, Andrew A ^e   Fava, Maurizio ^e   Kurian, Benji T ^c   Warden, Diane ^c   Morris, David W ^c,f   Luther, James F ^g   Husain, Mustafa M ^c   Cook, Ian A ^h   Lesser, Ira M ⁱ   Kornstein, Susan G ^j   Wisniewski, Stephen R ^g   Rush, A John ^k   Shelton, Richard C ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ HARBOR UCLA MEDICAL CENTER   (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k DUKE NUS MEDICAL SCHOOL   (Singapore)

more..

Author keywords

Bupropion; Escitalopram; Major depressive disorder; Melancholic features; Mirtazapine; Venlafaxine

Indexed keywords

AMFEBUTAMONE; ESCITALOPRAM; MIRTAZAPINE; PLACEBO; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MELANCHOLIA; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REMISSION; SELF CONCEPT; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CITALOPRAM; CYCLOHEXANOLS; DEPRESSION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 80052080314     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.04.032     Document Type: Article

References (50)

1. E.G. Altman, D. Hedeker, J.L. Peterson, and J.M. Davis The Altman self-rating mania scale Biol. Psychiatry 42 10 1997 948 955 (Pubitemid 27486450)
2. Amsterdam J.D. Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression J Psychopharmacol 12 3 Suppl B 1998 S99 111
3. I.M. Anderson SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability Depress. Anxiety 7 Suppl 1 1998 11 17
4. Angst, J., Stabl, M., 1992. Efficacy of moclobemide in different patient groups: a meta-analysis of studies. Psychopharmacology (Berl) 106 Suppl, S109-S113.
5. O. Benkert, G. Grunder, H. Wetzel, and D. Hackett A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia J. Psychiatr. Res. 30 6 1996 441 451 (Pubitemid 27032998)
6. P. Blier, H.E. Ward, P. Tremblay, L. Laberge, C. Hebert, and R. Bergeron Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study Am. J. Psychiatry 167 3 2010 281 288
7. Brown, W.A., 2007. Treatment response in melancholia. Acta Psychiatr. Scand. Suppl (433), 125-129. (Pubitemid 46114847)
8. G.E. Clerc, P. Ruimy, and J. Verdeau-Palles A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The venlafaxine French inpatient study group Int. Clin. Psychopharmacol. 9 3 1994 139 143 (Pubitemid 24317176)
9. W. Coryell, and R. Turner Outcome with desipramine therapy in subtypes of nonpsychotic major depression J. Affect. Disord. 9 2 1985 149 154 (Pubitemid 16240200)
10. E. Frank, D.J. Kupfer, T. Hamer, V.J. Grochocinski, and A.B. McEachran Maintenance treatment and psychobiologic correlates of endogenous subtypes J. Affect. Disord. 25 3 1992 181 189
11. M.B. Frisch, M.P. Clark, S.V. Rouse, M.D. Rudd, J.K. Paweleck, A. Greenstone, and D.A. Kopplin Predictive and treatment validity of life satisfaction and the quality of life inventory Assessment 12 2005 66 78 (Pubitemid 40900463)
12. V. Gentil, F. Kerr-Correa, R. Moreno, B.E. D'Arrigo, J.A. De Campos, M.F. Juruena, B. Lafer, D.H. Moreno, R.L. De Cassia Rodrigues, A. Tiosso, and E. Benedictis Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia J Psychopharmacol. 14 1 2000 61 66 (Pubitemid 30156540)
13. J.D. Guelfi, M. Ansseau, L. Timmerman, and S. Korsgaard Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features J. Clin. Psychopharmacol. 21 4 2001 425 431 (Pubitemid 32673032)
14. J.D. Guelfi, C. White, D. Hackett, J.Y. Guichoux, and G. Magni Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia J. Clin. Psychiatry 56 10 1995 450 458
15. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
16. A.T. Harvey, R.L. Rudolph, and S.H. Preskorn Evidence of the dual mechanisms of action of venlafaxine Arch. Gen. Psychiatry 57 5 2000 503 509 (Pubitemid 30257265)
17. M.G. Hildebrandt, K.B. Stage, and P. Kragh-Soerensen Gender differences in severity, symptomatology and distribution of melancholia in major depression Psychopathology 36 4 2003 204 212 (Pubitemid 37176881)
18. Kessing, L.V., 2007. Epidemiology of subtypes of depression. Acta Psychiatr. Scand. Suppl (433), 85-89. (Pubitemid 46114843)
19. A. Khan, R.L. Kolts, M.H. Rapaport, K.R. Krishnan, A.E. Brodhead, and W.A. Browns Magnitude of placebo response and drug-placebo differences across psychiatric disorders Psychol. Med. 35 5 2005 743 749 (Pubitemid 40716438)
20. A.Y. Khan, J. Carrithers, S.H. Preskorn, R. Lear, S.R. Wisniewski, R.A. John, D. Stegman, C. Kelley, K. Kreiner, A.A. Nierenberg, and M. Fava Clinical and demographic factors associated with DSM-IV melancholic depression Ann. Clin. Psychiatry 18 2 2006 91 98 (Pubitemid 43879896)
21. A.F. Leuchter, I.M. Lesser, M.H. Trivedi, A.J. Rush, D.W. Morris, D. Warden, M. Fava, S.R. Wisniewski, J.F. Luther, M. Perales, B.N. Gaynes, and J.W. Stewart An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder J Psychiatr. Pract. 14 5 2008 271 280
22. A.M. Leventhal, and L.P. Rehm The empirical status of melancholia: implications for psychology Clin. Psychol. Rev. 25 1 2005 25 44 (Pubitemid 41556532)
23. J. Levine, and N.R. Schooler SAFTEE: a technique for the systematic assessment of side effects in clinical trials Psychopharmacol. Bull. 22 2 1986 343 381 (Pubitemid 16043808)
24. C.H. Mallinckrodt, J.G. Watkin, C. Liu, M.M. Wohlreich, and J. Raskin Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features BMC Psychiatry 5 2005 1
25. P.J. McGrath, A.Y. Khan, M.H. Trivedi, J.W. Stewart, D.W. Morris, S.R. Wisniewski, S. Miyahara, A.A. Nierenberg, M. Fava, and J.A. Rush Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report J. Clin. Psychiatry 69 12 2008 1847 1855
26. J.C. Mundt, I.M. Marks, M.K. Shear, and J.H. Greist The work and social adjustment scale: a simple measure of impairment in functioning Br. J. Psychiatry 180 2002 461 464 (Pubitemid 34499343)
27. G. Parker, D. Hadzi-Pavlovic, H. Brodaty, P. Boyce, P. Mitchell, K. Wilhelm, and I. Hickie Predicting the course of melancholic and nonmelancholic depression. A naturalistic comparison study J. Nerv. Ment. Dis. 180 11 1992 693 702 (Pubitemid 23009550)
28. P.J. Perry Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants J. Affect. Disord. 39 1 1996 1 6 (Pubitemid 26235318)
29. E.D. Peselow, M.P. Sanfilipo, C. Difiglia, and R.R. Fieve Melancholic/endogenous depression and response to somatic treatment and placebo Am. J. Psychiatry 149 10 1992 1324 1334
30. B.A. Prusoff, M.M. Weissman, G.L. Klerman, and B.J. Rounsaville Research diagnostic criteria subtypes of depression. Their role as predictors of differential response to psychotherapy and drug treatment Arch. Gen. Psychiatry 37 7 1980 796 801 (Pubitemid 10090645)
31. A.J. Rush Combining antidepressant medications: a good idea? Am. J. Psychiatry 167 3 2010 241 243
32. A.J. Rush, T.J. Carmody, H.M. Ibrahim, M.H. Trivedi, M.M. Biggs, K. Shores-Wilson, M.L. Crismon, M.G. Toprac, and T.M. Kashner Comparison of self-report and clinician ratings on two inventories of depressive symptomatology Psychiatr. Serv. 57 6 2006 829 837 (Pubitemid 43846295)
33. A.J. Rush, C.M. Gullion, M.R. Basco, R.B. Jarrett, and M.H. Trivedi The Inventory of Depressive Symptomatology (IDS): psychometric properties Psychol. Med. 26 3 1996 477 486 (Pubitemid 26142491)
34. A.J. Rush, M.H. Trivedi, H.M. Ibrahim, T.J. Carmody, B. Arnow, D.N. Klein, J.C. Markowitz, P.T. Ninan, S. Kornstein, R. Manber, M.E. Thase, J.H. Kocsis, and M.B. Keller The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression Biol. Psychiatry 54 5 2003 573 583 (Pubitemid 37289444)
35. A.J. Rush, M.H. Trivedi, J.W. Stewart, A.A. Nierenberg, M. Fava, B.T. Kurian, D. Warden, D.W. Morris, J.F. Luther, M.M. Husain, I.A. Cook, R.C. Shelton, I.M. Lesser, S.G. Kornstein, and S.R. Wisniewski Combining Medications to Enhance Depression Outcomes (CO-MED): acute and long-term outcomes: a single-blind randomized study Am. J. Psychiatry 168 2011 689 701 Ref Type: Generic
36. A.J. Rush, M.H. Trivedi, S.R. Wisniewski, A.A. Nierenberg, J.W. Stewart, D. Warden, G. Niederehe, M.E. Thase, P.W. Lavori, B.D. Lebowitz, P.J. McGrath, J.F. Rosenbaum, H.A. Sackeim, D.J. Kupfer, J. Luther, and M. Fava Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report Am. J. Psychiatry 163 11 2006 1905 1917 (Pubitemid 44807782)
37. A.J. Rush, and J.E. Weissenburger Melancholic symptom features and DSM-IV Am. J. Psychiatry 151 4 1994 489 498 (Pubitemid 24115811)
38. A.J. Rush, S.R. Wisniewski, D. Warden, J.F. Luther, L.L. Davis, M. Fava, A.A. Nierenberg, and M.H. Trivedi Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features Arch. Gen. Psychiatry 65 8 2008 870 880
39. A.J. Rush, M. Zimmerman, S.R. Wisniewski, M. Fava, S.D. Hollon, D. Warden, M.M. Biggs, K. Shores-Wilson, R.C. Shelton, J.F. Luther, B. Thomas, and M.H. Trivedi Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features J. Affect. Disord. 87 1 2005 43 55 (Pubitemid 40828202)
40. O. Sangha, G. Stucki, M.H. Liang, A.H. Fossel, and J.N. Katz The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research Arthritis Rheum. 49 2 2003 156 163 (Pubitemid 36418272)
41. D.V. Sheehan, C.B. Nemeroff, M.E. Thase, and R. Entsuah Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features Int. Clin. Psychopharmacol. 24 2 2009 61 86
42. M.E. Thase, and E.S. Friedman Is psychotherapy an effective treatment for melancholia and other severe depressive states? J. Affect. Disord. 54 1-2 1999 1 19 (Pubitemid 29287668)
43. Trivedi, M. H., Morris, D. W., Wisniewski, S. R., Fava, M., Gollan, J., Nierenberg, A. A., Gaynes, B. N., Husain, M. M., Luther, J. F., Zisook, S., and Rush, A. J. Concise Associated Symptoms Tracking (CAST) Scale and Concise Health Risk Tracking (CHRT) Scale: brief self and clinician ratings of suicidality and associated symptoms. Poster presented at the 50th National Clinical Drug Evaluation Unity (NCDEU) Annual Meeting, Boca Raton, FL June 14-17, 2010. 2010. Ref Type: Generic
44. Trivedi M.H., A.J. Rush, B.N. Gaynes, J.W. Stewart, S.R. Wisniewski, D. Warden, L. Ritz, J.F. Luther, D. Stegman, J. veaugh-Geiss, and R. Howland Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care Neuropsychopharmacology 32 12 2007 2479 2489 (Pubitemid 350126843)
45. M.H. Trivedi, A.J. Rush, S.R. Wisniewski, A.A. Nierenberg, D. Warden, L. Ritz, G. Norquist, R.H. Howland, B. Lebowitz, P.J. McGrath, K. Shores-Wilson, M.M. Biggs, G.K. Balasubramani, and M. Fava Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am. J. Psychiatry 163 1 2006 28 40 (Pubitemid 43050100)
46. M. Tzanakaki, M. Guazzelli, I. Nimatoudis, N.P. Zissis, E. Smeraldi, and F. Rizzo Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia Int. Clin. Psychopharmacol. 15 1 2000 29 34 (Pubitemid 30058136)
47. E.A. Walker, W.J. Katon, J. Russo, K.M. Von, E. Lin, G. Simon, T. Bush, E. Ludman, and J. Unutzer Predictors of outcome in a primary care depression trial J. Gen. Intern. Med. 15 12 2000 859 867 (Pubitemid 32011835)
48. S.R. Wisniewski, A.J. Rush, G.K. Balasubramani, M.H. Trivedi, and A.A. Nierenberg Self-rated global measure of the frequency, intensity, and burden of side effects J. Psychiatr. Pract. 12 2 2006 71 79 (Pubitemid 44284089)
49. M. Zimmerman, and R.L. Spitzer Melancholia: from DSM-III to DSM-III-R Am. J. Psychiatry 146 1 1989 20 28 (Pubitemid 19033217)
50. S. Zisook, A.J. Rush, B.R. Haight, D.C. Clines, and C.B. Rockett Use of bupropion in combination with serotonin reuptake inhibitors Biol. Psychiatry 59 3 2006 203 210 (Pubitemid 43208965)